Does the Chimerization Process Affect the Immunochemical Properties of WNV-Neutralizing Antibody 900? [PDF]
Isaeva AA +12 more
europepmc +1 more source
Efgartigimod as Fast-Acting Rescue Therapy in Very Late-Onset Myasthenia Gravis. [PDF]
Rini N +4 more
europepmc +1 more source
Demonstration of Functional Similarity of Proposed Biosimilar ABP 501 to Adalimumab [PDF]
core +1 more source
Expanding Evidence of Leptomeningeal Involvement in MOGAD and Its Relevance to Its Pathophysiology. [PDF]
Cacciaguerra L, Flanagan EP.
europepmc +1 more source
Immunotherapy in Chronic Inflammatory Demyelinating Polyneuropathy and the Emerging Role of Efgartigimod. [PDF]
Park JS, Kang M.
europepmc +1 more source
Does a Polycistronic 2A Design Enable Functional FcRn Production for Antibody Pharmacokinetic Studies? [PDF]
Nesmeyanova VS +6 more
europepmc +1 more source
Nipocalimab-aahu in generalised myasthenia gravis: A new Fc receptor-targeted option for antibody-positive patients. [PDF]
Hussain JM +3 more
europepmc +1 more source
Mechanistic insights into the impact of prenatal viral infections on maternal and offspring immunity. [PDF]
Salem GM +7 more
europepmc +1 more source

